CoChat

Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors

Panecka-Hofman, Joanna, Pöhner, Ina, Spyrakis, Francesca, Zeppelin, Talia, Di Pisa, Flavio, Dello Iacono, Lucia, Bonucci, Alessio, Quotadamo, Antonio, Venturelli, Alberto, Mangani, Stefano, Costi, Maria Paola, Wade, Rebecca C. · 2017 · Biochimica et Biophysica Acta (BBA) - General Subjects
Cited by 24

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbagen.2017.09.012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 85

  1. Dwivedi, 2015, Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs), Drug Discov. Today, 20, 863, 10.1016/j.drudis.2015.03.004 · DOI · Paper page
  2. Stuart, 2008, Kinetoplastids: related protozoan pathogens, different diseases., J. Clin. Invest., 118, 1301, 10.1172/JCI33945 · DOI · Paper page
  3. Barrett, 2012, Management of trypanosomiasis and leishmaniasis, Br. Med. Bull., 104, 175, 10.1093/bmb/lds031 · DOI · Paper page
  4. Wibowo, 2013, Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition, Proc. Natl. Acad. Sci. U. S. A., 110, 15180, 10.1073/pnas.1308827110 · DOI · Paper page
  5. Ouellette, 2002, Pterin transport and metabolism in Leishmania and related trypanosomatid parasites., Int. J. Parasitol., 32, 385, 10.1016/S0020-7519(01)00346-0 · doi:10.1016/s0020-7519(01)00346-0
  6. Anderson, 2011, Antifolate agents: a patent review (2006–2010)., Expert Opin. Ther. Pat., 21, 1293, 10.1517/13543776.2011.587804 · doi:10.1517/13543776.2011.587804
  7. Nare, 1997, New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity., Parasitology, 114 Suppl, S101, 10.1017/S0031182097001133 · DOI
  8. Robello, 1997, A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi., Mol. Biochem. Parasitol., 90, 525, 10.1016/S0166-6851(97)00207-7 · DOI
  9. Vickers, 2011, Folate metabolic pathways in Leishmania, Essays Biochem., 51, 63, 10.1042/bse0510063 · DOI
  10. Cavazzuti, 2008, Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development., Proc. Natl. Acad. Sci. U. S. A., 105, 1448, 10.1073/pnas.0704384105 · doi:10.1073/pnas.0704384105
  11. Gibson, 2016, Trypanosoma brucei DHFR-TS revisited: characterisation of a bifunctional and highly unstable recombinant dihydrofolate reductase-thymidylate synthase., PLoS Negl.Trop. Dis., 10, e0004714, 10.1371/journal.pntd.0004714 · doi:10.1371/journal.pntd.0004714
  12. Meek, 1985, Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica., Biochemistry (Mosc.), 24, 678, 10.1021/bi00324a021 · DOI · Paper page
  13. Zuccotto, 1999, The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase., Bioorg. Med. Chem. Lett., 9, 1463, 10.1016/S0960-894X(99)00213-9 · doi:10.1016/s0960-894x(99)00213-9
  14. Cody, 2009, Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes, Biochemistry (Mosc.), 48, 1702, 10.1021/bi801960h · doi:10.1021/bi801960h
  15. Dawson, 2006, Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate., Mol. Microbiol., 61, 1457, 10.1111/j.1365-2958.2006.05332.x · DOI
  16. Gilli, 1990, Thermodynamic study of the interaction of methotrexate, its metabolites, and new antifolates with thymidylate synthase: influence of FdUMP., Biochem. Pharmacol., 40, 2241, 10.1016/0006-2952(90)90718-Z · doi:10.1016/0006-2952(90)90718-z
  17. Corona, 2012, Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors., J. Med. Chem., 55, 8318, 10.1021/jm300563f · DOI
  18. Borsari, 2016, Profiling of flavonol derivatives for the development of antitrypanosomatidic Drugs., J. Med. Chem., 59, 7598, 10.1021/acs.jmedchem.6b00698 · DOI
  19. Tulloch, 2010, Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases., J. Med. Chem., 53, 221, 10.1021/jm901059x · doi:10.1021/jm901059x
  20. Ferrari, 2011, Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase., J. Med. Chem., 54, 211, 10.1021/jm1010572 · DOI
  21. Mpamhanga, 2009, One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening., J. Med. Chem., 52, 4454, 10.1021/jm900414x · DOI
  22. Spinks, 2011, Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1., Chemmedchem, 6, 302, 10.1002/cmdc.201000450 · doi:10.1002/cmdc.201000450
  23. Cunningham, 2002, Parasitic adaptive mechanisms in infection by Leishmania, Exp. Mol. Pathol., 72, 132, 10.1006/exmp.2002.2418 · DOI · Paper page
  24. Liu, 2012, The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response., Front. Cell. Infect. Microbiol., 2, 83, 10.3389/fcimb.2012.00083 · DOI · Paper page
  25. de Souza, 2010, Review on Trypanosoma cruzi: host cell interaction., Int. J. Cell Biol., 2010, 10.1155/2010/295394 · DOI · Paper page
  26. Fiehn, 2010, Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment., Clin. Exp. Rheumatol., 28, S40
  27. Lu, 2014, Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitis., Clin. Immunol., 150, 64, 10.1016/j.clim.2013.10.010 · DOI
  28. UniProt Consortium, 2015, UniProt: a hub for protein information., Nucleic Acids Res., 43, D204, 10.1093/nar/gku989 · DOI · Paper page
  29. Sievers, 2011, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega., Mol. Syst. Biol., 7, 539, 10.1038/msb.2011.75 · DOI · Paper page
  30. Beitz, 2000, TeXshade: shading and labeling of multiple sequence alignments using LaTeX2e, Bioinformatics, 16, 135, 10.1093/bioinformatics/16.2.135 · DOI · Paper page
  31. Sussman, 1998, Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules., Acta Crystallogr. D Biol. Crystallogr., 54, 1078, 10.1107/S0907444998009378 · DOI · Paper page
  32. Chayen, 1992, Microbatch crystallization under oil – a new technique allowing many small-volume crystallization trials, J. Cryst. Growth, 122, 176, 10.1016/0022-0248(92)90241-A · DOI · Paper page
  33. Leslie, 2006, The integration of macromolecular diffraction data., Acta Crystallogr. D Biol. Crystallogr., 62, 48, 10.1107/S0907444905039107 · DOI · Paper page
  34. Evans, 2006, Scaling and assessment of data quality., Acta Crystallogr. D Biol. Crystallogr., 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
  35. Winn, 2011, Overview of the CCP4 suite and current developments., Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
  36. Vagin, 2010, Molecular replacement with MOLREP., Acta Crystallogr. D Biol. Crystallogr., 66, 22, 10.1107/S0907444909042589 · DOI · Paper page
  37. Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures., Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI · Paper page
  38. Emsley, 2004, Coot: model-building tools for molecular graphics., Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  39. Laskowski, 1993, PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944 · DOI · Paper page
  40. Potterton, 2004, Developments in the CCP4 molecular-graphics project., Acta Crystallogr. D Biol. Crystallogr., 60, 2288, 10.1107/S0907444904023716 · DOI · Paper page
  41. Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs., Nucleic Acids Res., 25, 3389, 10.1093/nar/25.17.3389 · DOI · Paper page
  42. Arnold, 2009, The protein model portal., J. Struct. Funct. Genomics, 10, 1, 10.1007/s10969-008-9048-5 · DOI · Paper page
  43. Hooft, 1996, Errors in protein structures., Nature, 381, 272, 10.1038/381272a0 · DOI · Paper page
  44. Friesner, 2004, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy., J. Med. Chem., 47, 1739, 10.1021/jm0306430 · DOI · Paper page
  45. Friesner, 2006, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes., J. Med. Chem., 49, 6177, 10.1021/jm051256o · DOI · Paper page
  46. Shelley, 2007, Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules., J. Comput. Aided Mol. Des., 21, 681, 10.1007/s10822-007-9133-z · DOI · Paper page
  47. Greenwood, 2010, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, J. Comput. Aided Mol. Des., 24, 591, 10.1007/s10822-010-9349-1 · DOI · Paper page
  48. Bas, 2008, Very fast prediction and rationalization of pKa values for protein-ligand complexes., Proteins, 73, 765, 10.1002/prot.22102 · DOI · Paper page
  49. Jorgensen, 1996, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc., 118, 11225, 10.1021/ja9621760 · DOI · Paper page
  50. Baroni, 2007, A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application., J. Chem. Inf. Model., 47, 279, 10.1021/ci600253e · DOI · Paper page
  51. Spyrakis, 2015, A pipeline to enhance ligand virtual screening: integrating molecular dynamics and fingerprints for ligand and proteins., J. Chem. Inf. Model., 55, 2256, 10.1021/acs.jcim.5b00169 · DOI
  52. Siragusa, 2015, BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity., Proteins, 83, 517, 10.1002/prot.24753 · DOI · Paper page
  53. Carosati, 2004, Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field, J. Med. Chem., 47, 5114, 10.1021/jm0498349 · doi:10.1021/jm0498349
  54. Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 · DOI · Paper page
  55. Halgren, 2007, New method for fast and accurate binding-site identification and analysis., Chem. Biol. Drug Des., 69, 146, 10.1111/j.1747-0285.2007.00483.x · DOI · Paper page
  56. Halgren, 2009, Identifying and characterizing binding sites and assessing druggability., J. Chem. Inf. Model., 49, 377, 10.1021/ci800324m · DOI · Paper page
  57. Kokh, 2013, TRAPP: a tool for analysis of transient binding pockets in proteins., J. Chem. Inf. Model., 53, 1235, 10.1021/ci4000294 · DOI
  58. Gourley, 2001, Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites., Nat. Struct. Biol., 8, 521, 10.1038/88584 · doi:10.1038/88584
  59. Ong, 2011, Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major., J. Biol. Chem., 286, 10429, 10.1074/jbc.M110.209593 · DOI
  60. Khalaf, 2014, Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1., J. Med. Chem., 57, 6479, 10.1021/jm500483b · DOI
  61. Knighton, 1994, Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase., Nat. Struct. Biol., 1, 186, 10.1038/nsb0394-186 · DOI · Paper page
  62. Senkovich, 2009, Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate, Acta Crystallogr. D Biol. Crystallogr., 65, 704, 10.1107/S090744490901230X · doi:10.1107/s090744490901230x
  63. Antosiewicz, 2016, Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells., J. Biomol. Struct. Dyn., 1
  64. Wang, 2016, Substrate channeling between the human dihydrofolate reductase and thymidylate synthase., Protein Sci., 25, 79, 10.1002/pro.2720 · DOI
  65. Ferrari, 2003, Inhibitor specificity via protein dynamics: insights from the design of antibacterial agents targeted against thymidylate synthase., Chem. Biol., 10, 1183, 10.1016/j.chembiol.2003.11.012 · DOI
  66. Liang, 1998, Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase., Biochemistry (Mosc.), 37, 12195, 10.1021/bi9803168 · doi:10.1021/bi9803168
  67. Atreya, 2003, Probing electrostatic channeling in protozoal bifunctional thymidylate synthase-dihydrofolate reductase using site-directed mutagenesis., J. Biol. Chem., 278, 28901, 10.1074/jbc.M212689200 · DOI
  68. Elcock, 1996, Electrostatic channeling in the bifunctional enzyme dihydrofolate reductase-thymidylate synthase., J. Mol. Biol., 262, 370, 10.1006/jmbi.1996.0520 · doi:10.1006/jmbi.1996.0520
  69. Garg, 2015, Conservation and role of electrostatics in thymidylate synthase., Sci. Rep., 5, 17356, 10.1038/srep17356 · doi:10.1038/srep17356
  70. Lee, 1996, Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4., Biochemistry (Mosc.), 35, 7012, 10.1021/bi960028g · DOI
  71. Pozzi, 2012, The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism., Acta Crystallogr. Sect. D: Biol. Crystallogr., 68, 1232, 10.1107/S0907444912026236 · DOI
  72. Schormann, 2008, Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function., Proteins, 73, 889, 10.1002/prot.22115 · DOI
  73. Schormann, 2010, Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase, Bioorg. Med. Chem., 18, 4056, 10.1016/j.bmc.2010.04.020 · doi:10.1016/j.bmc.2010.04.020
  74. Wilcken, 2011, Addressing methionine in molecular design through directed sulfur-halogen bonds, J. Chem. Theory Comput., 7, 2307, 10.1021/ct200245e · DOI
  75. Imai, 2007, Propensities of polar and aromatic amino acids in noncanonical interactions: nonbonded contacts analysis of protein-ligand complexes in crystal structures, J. Med. Chem., 50, 1189, 10.1021/jm061038a · doi:10.1021/jm061038a
  76. Wallnoefer, 2010, Dispersion dominated halogen-pi interactions: energies and locations of minima, Phys. Chem. Chem. Phys., 12, 14941, 10.1039/c0cp00607f · DOI
  77. Henrich, 2008, On the use of PIPSA to guide target-selective drug design., Chemmedchem, 3, 413, 10.1002/cmdc.200700154 · doi:10.1002/cmdc.200700154
  78. Arrebola, 1994, Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells., J. Biol. Chem., 269, 10590, 10.1016/S0021-9258(17)34100-5 · doi:10.1016/s0021-9258(17)34100-5
  79. Iwai, 1981, Purification and properties of dihydrofolate reductase from Crithidia fasciculata, Agric. Biol. Chem., 45, 113
  80. Jarabak, 1971, A soluble dihydrofolate reductase from human placenta: purification and properties., Arch. Biochem. Biophys., 142, 417, 10.1016/0003-9861(71)90505-4 · DOI
  81. Atreya, 2003, A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase, J. Biol. Chem., 278, 14092, 10.1074/jbc.M212690200 · doi:10.1074/jbc.m212690200
  82. Finn, 2016, The Pfam protein families database: towards a more sustainable future., Nucleic Acids Res., 44, D279, 10.1093/nar/gkv1344 · DOI · Paper page
  83. Montgomery, 1979, Analogues of methotrexate, J. Med. Chem., 22, 862, 10.1021/jm00193a021 · doi:10.1021/jm00193a021
  84. Piper, 1982, 10-Propargylaminopterin and alkyl homologues of methotrexate as inhibitors of folate metabolism, J. Med. Chem., 25, 877, 10.1021/jm00349a024 · doi:10.1021/jm00349a024
  85. Synold, 1996, Role of folylpolygutamate synthetase (FPGS) in antifolate chemotherapy; a biochemical and clinical update., Leuk. Lymphoma, 21, 9, 10.3109/10428199609067573 · doi:10.3109/10428199609067573

Cited by

See all 24

Metadata

Authors
Panecka-Hofman, J., Pöhner, I., Spyrakis, F., Zeppelin, T., Di Pisa, F., Dello Iacono, L., Bonucci, A., Quotadamo, A., Venturelli, A., Mangani, S., Costi, M. P., & Wade, R. C.
Venue
Biochimica et Biophysica Acta (BBA) - General Subjects
Publisher
Elsevier BV
Published
2017-12
Volume
1861
Issue
12
Pages
3215-3230
ISSN
0304-4165
Cited by
24
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors. https://app.cochat.ai/papers/10.1016/j.bbagen.2017.09.012
The paper
Panecka-Hofman, J., Pöhner, I., Spyrakis, F., Zeppelin, T., Di Pisa, F., Dello Iacono, L., Bonucci, A., Quotadamo, A., Venturelli, A., Mangani, S., Costi, M. P., & Wade, R. C. (2017). Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors. Biochimica et Biophysica Acta (BBA) - General Subjects. https://doi.org/10.1016/j.bbagen.2017.09.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.